2:00 PM - 6:15 PM

9:00 AM - 7:15 PM

9:00 AM - 1:45 PM

Rapid advances in disease management require the ongoing attention of healthcare professionals. This course will address the implications of new PK/PD information on strategies for clinical management of patients with HIV, HBV and HCV infections.
Information will be presented through a mix of didactic lectures and clinically relevant cases developed by an expert panel of clinicians and researchers. The three-day course will bring together researchers and clinicians from various parts of the world to discuss pro and cons of current PK/PD strategies in anti-infective area. Each topic focus on preclinical, translational and clinical aspects and will provide opportunity for discussion and input from the audience. This meeting will be a valuable experience for all involved in infectious diseases, as researchers or prescribers of anti-infective agents.

Participants will be taught on learning goals:

• Recognize the role of PK/PD parameters for the management of HIV, HBV and HCV infections.
• Focus on recent developments regarding PK variability of antivirals and its association with specific tissue drug penetration and clearance.
• Describe the challenges of HIV, HBV and HCV treatment as it relates to cure and selection of drug resistance.
• Develop strategies to modify HIV and anti-hepatitis treatment regimens based on individual patient response.
• Devise a plan to manage drug interactions and adverse effects of HIV, HBV and HCV treatments and optimize treatment responses.
• Present real and typical clinical scenarios, discuss findings and management in the light of current PK/PD data and clinical practices guidelines.

HealthData Consulting S.r.l. 

via Morghen 27, 10143 Turin, Tel. +39 011 0267950 - Fax +39 011 0267954 - Mail segreteria@hdcons.it, P.IVA 01429280058, REA 1125824